Bootcamp during neoadjuvant chemotherapy for breast cancer: A randomized pilot trial

Roshni Rao, Veronica Cruz, Yan Peng, Amy Harker-Murray, Barbara B. Haley, Hong Zhao, Xian Jin Xie, David Euhus

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Introduction: Exercise may improve cancer outcomes. Neoadjuvant chemotherapy (NC) for breast cancer provides a unique setting to evaluate intervention effects. Treatments leading to decreased post-neoadjuvant Ki-67 levels, smaller tumor size, and higher pathologic response are associated with improved survival and lower recurrence. This randomized, prospective pilot trial evaluates the feasibility of supervised exercise during NC for breast cancer. Methods: Stage II-III, ER positive, cancer patients with BMI >25 receiving NC were randomized to standard NC with supervised bootcamp (NC + BC) or NC alone. Ki-67, C-peptide, BMI, and tumor size were measured before chemotherapy and at time of surgery. Results: There were no initial differences between groups in regards to tumor size, C-peptide, BMI, and Ki-67. The NC + BC (n = 5) group had a lower mean BMI at the conclusion of NC compared with those (n = 5) in the NC group (28.0 versus 35.8, P = 0.03). Final tumor size was 2.59 cm in the NC + BC group versus 3.16 cm for NC (P = 0.76) Mean Ki-67 for NC + BC was 7% versus 29% with NC (P = 0.14). C-peptide (ng/mL) was equivalent between the two groups (4.55 NC + BC versus 4.74 NC, P = 0.85). Conclusions: Adding a supervised exercise program to NC is feasible, decreases BMI, and may lead to lower Ki-67 levels and improved survival.

Original languageEnglish (US)
Pages (from-to)39-46
Number of pages8
JournalBreast Cancer: Basic and Clinical Research
Volume6
Issue number1
DOIs
StatePublished - 2012

Fingerprint

Breast Neoplasms
Drug Therapy
C-Peptide
Neoplasms
Exercise
Survival
Recurrence

Keywords

  • Breast cancer
  • Exercise
  • Ki-67
  • Neoadjuvant chemotherapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Bootcamp during neoadjuvant chemotherapy for breast cancer : A randomized pilot trial. / Rao, Roshni; Cruz, Veronica; Peng, Yan; Harker-Murray, Amy; Haley, Barbara B.; Zhao, Hong; Xie, Xian Jin; Euhus, David.

In: Breast Cancer: Basic and Clinical Research, Vol. 6, No. 1, 2012, p. 39-46.

Research output: Contribution to journalArticle

@article{e6aa332fdfd04c91ae64836d1f5a5aea,
title = "Bootcamp during neoadjuvant chemotherapy for breast cancer: A randomized pilot trial",
abstract = "Introduction: Exercise may improve cancer outcomes. Neoadjuvant chemotherapy (NC) for breast cancer provides a unique setting to evaluate intervention effects. Treatments leading to decreased post-neoadjuvant Ki-67 levels, smaller tumor size, and higher pathologic response are associated with improved survival and lower recurrence. This randomized, prospective pilot trial evaluates the feasibility of supervised exercise during NC for breast cancer. Methods: Stage II-III, ER positive, cancer patients with BMI >25 receiving NC were randomized to standard NC with supervised bootcamp (NC + BC) or NC alone. Ki-67, C-peptide, BMI, and tumor size were measured before chemotherapy and at time of surgery. Results: There were no initial differences between groups in regards to tumor size, C-peptide, BMI, and Ki-67. The NC + BC (n = 5) group had a lower mean BMI at the conclusion of NC compared with those (n = 5) in the NC group (28.0 versus 35.8, P = 0.03). Final tumor size was 2.59 cm in the NC + BC group versus 3.16 cm for NC (P = 0.76) Mean Ki-67 for NC + BC was 7{\%} versus 29{\%} with NC (P = 0.14). C-peptide (ng/mL) was equivalent between the two groups (4.55 NC + BC versus 4.74 NC, P = 0.85). Conclusions: Adding a supervised exercise program to NC is feasible, decreases BMI, and may lead to lower Ki-67 levels and improved survival.",
keywords = "Breast cancer, Exercise, Ki-67, Neoadjuvant chemotherapy",
author = "Roshni Rao and Veronica Cruz and Yan Peng and Amy Harker-Murray and Haley, {Barbara B.} and Hong Zhao and Xie, {Xian Jin} and David Euhus",
year = "2012",
doi = "10.4137/BCBCR.S9221",
language = "English (US)",
volume = "6",
pages = "39--46",
journal = "Breast Cancer: Basic and Clinical Research",
issn = "1178-2234",
publisher = "Libertas Academica Ltd.",
number = "1",

}

TY - JOUR

T1 - Bootcamp during neoadjuvant chemotherapy for breast cancer

T2 - A randomized pilot trial

AU - Rao, Roshni

AU - Cruz, Veronica

AU - Peng, Yan

AU - Harker-Murray, Amy

AU - Haley, Barbara B.

AU - Zhao, Hong

AU - Xie, Xian Jin

AU - Euhus, David

PY - 2012

Y1 - 2012

N2 - Introduction: Exercise may improve cancer outcomes. Neoadjuvant chemotherapy (NC) for breast cancer provides a unique setting to evaluate intervention effects. Treatments leading to decreased post-neoadjuvant Ki-67 levels, smaller tumor size, and higher pathologic response are associated with improved survival and lower recurrence. This randomized, prospective pilot trial evaluates the feasibility of supervised exercise during NC for breast cancer. Methods: Stage II-III, ER positive, cancer patients with BMI >25 receiving NC were randomized to standard NC with supervised bootcamp (NC + BC) or NC alone. Ki-67, C-peptide, BMI, and tumor size were measured before chemotherapy and at time of surgery. Results: There were no initial differences between groups in regards to tumor size, C-peptide, BMI, and Ki-67. The NC + BC (n = 5) group had a lower mean BMI at the conclusion of NC compared with those (n = 5) in the NC group (28.0 versus 35.8, P = 0.03). Final tumor size was 2.59 cm in the NC + BC group versus 3.16 cm for NC (P = 0.76) Mean Ki-67 for NC + BC was 7% versus 29% with NC (P = 0.14). C-peptide (ng/mL) was equivalent between the two groups (4.55 NC + BC versus 4.74 NC, P = 0.85). Conclusions: Adding a supervised exercise program to NC is feasible, decreases BMI, and may lead to lower Ki-67 levels and improved survival.

AB - Introduction: Exercise may improve cancer outcomes. Neoadjuvant chemotherapy (NC) for breast cancer provides a unique setting to evaluate intervention effects. Treatments leading to decreased post-neoadjuvant Ki-67 levels, smaller tumor size, and higher pathologic response are associated with improved survival and lower recurrence. This randomized, prospective pilot trial evaluates the feasibility of supervised exercise during NC for breast cancer. Methods: Stage II-III, ER positive, cancer patients with BMI >25 receiving NC were randomized to standard NC with supervised bootcamp (NC + BC) or NC alone. Ki-67, C-peptide, BMI, and tumor size were measured before chemotherapy and at time of surgery. Results: There were no initial differences between groups in regards to tumor size, C-peptide, BMI, and Ki-67. The NC + BC (n = 5) group had a lower mean BMI at the conclusion of NC compared with those (n = 5) in the NC group (28.0 versus 35.8, P = 0.03). Final tumor size was 2.59 cm in the NC + BC group versus 3.16 cm for NC (P = 0.76) Mean Ki-67 for NC + BC was 7% versus 29% with NC (P = 0.14). C-peptide (ng/mL) was equivalent between the two groups (4.55 NC + BC versus 4.74 NC, P = 0.85). Conclusions: Adding a supervised exercise program to NC is feasible, decreases BMI, and may lead to lower Ki-67 levels and improved survival.

KW - Breast cancer

KW - Exercise

KW - Ki-67

KW - Neoadjuvant chemotherapy

UR - http://www.scopus.com/inward/record.url?scp=84863062051&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863062051&partnerID=8YFLogxK

U2 - 10.4137/BCBCR.S9221

DO - 10.4137/BCBCR.S9221

M3 - Article

C2 - 22399859

AN - SCOPUS:84863062051

VL - 6

SP - 39

EP - 46

JO - Breast Cancer: Basic and Clinical Research

JF - Breast Cancer: Basic and Clinical Research

SN - 1178-2234

IS - 1

ER -